FXR keeps inactivated under physiological conditions, however, knocking out of FXR contributes to the development of nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, hepatic fibrosis, and even hepatocellular carcinoma [11, 12]. Here, NR1H4 is linked to metabolic dysfunction-associated steatotic liver disease.